All Companies
Ticker AKAN
We can't analyze this yet — its market data looks wrong
You reached the page — here's exactly what AKAN is, and why it's out of scope for now.
What this ticker is
AKAN
Akanda Corp
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
Why we can't analyze it yet
Data provider – reported cap ($2,628,487) is 3.1× off vs SEC filings (1,983,546 shares × $4.06 ≈ $8,053,197); source data unreliable
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
data_corrupt